Bicycle Therapeutics Statistics
Total Valuation
BCYC has a market cap or net worth of $253.74 million. The enterprise value is -$202.00 million.
| Market Cap | 253.74M |
| Enterprise Value | -202.00M |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BCYC has 70.09 million shares outstanding. The number of shares has increased by 0.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 70.09M |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 39.03% |
| Float | 7.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.04 |
| Forward PS | 31.15 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.09, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.09 |
| Quick Ratio | 11.75 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -793.95 |
Financial Efficiency
Return on equity (ROE) is -25.24% and return on invested capital (ROIC) is -16.83%.
| Return on Equity (ROE) | -25.24% |
| Return on Assets (ROA) | -14.46% |
| Return on Invested Capital (ROIC) | -16.83% |
| Return on Capital Employed (ROCE) | -29.47% |
| Weighted Average Cost of Capital (WACC) | 12.45% |
| Revenue Per Employee | $290,028 |
| Profits Per Employee | -$492,326 |
| Employee Count | 288 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BCYC has paid $2.70 million in taxes.
| Income Tax | 2.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.14% in the last 52 weeks. The beta is 1.61, so BCYC's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -55.14% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 4.55 |
| Relative Strength Index (RSI) | 46.71 |
| Average Volume (20 Days) | 439,997 |
Short Selling Information
The latest short interest is 3.45 million, so 8.84% of the outstanding shares have been sold short.
| Short Interest | 3.45M |
| Short Previous Month | 3.30M |
| Short % of Shares Out | 8.84% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.22 |
Income Statement
In the last 12 months, BCYC had revenue of $83.53 million and -$141.79 million in losses. Loss per share was -$2.03.
| Revenue | 83.53M |
| Gross Profit | -80.53M |
| Operating Income | -154.03M |
| Pretax Income | -139.09M |
| Net Income | -141.79M |
| EBITDA | -149.42M |
| EBIT | -154.03M |
| Loss Per Share | -$2.03 |
Balance Sheet
The company has $469.93 million in cash and $14.18 million in debt, with a net cash position of $455.74 million or $6.50 per share.
| Cash & Cash Equivalents | 469.93M |
| Total Debt | 14.18M |
| Net Cash | 455.74M |
| Net Cash Per Share | $6.50 |
| Equity (Book Value) | 505.28M |
| Book Value Per Share | 7.22 |
| Working Capital | 493.10M |
Cash Flow
In the last 12 months, operating cash flow was -$175.18 million and capital expenditures -$1.86 million, giving a free cash flow of -$177.04 million.
| Operating Cash Flow | -175.18M |
| Capital Expenditures | -1.86M |
| Depreciation & Amortization | 4.61M |
| Net Borrowing | -199,000 |
| Free Cash Flow | -177.04M |
| FCF Per Share | -$2.53 |
Margins
Gross margin is -96.41%, with operating and profit margins of -184.40% and -169.75%.
| Gross Margin | -96.41% |
| Operating Margin | -184.40% |
| Pretax Margin | -166.52% |
| Profit Margin | -169.75% |
| EBITDA Margin | -178.89% |
| EBIT Margin | -184.40% |
| FCF Margin | n/a |
Dividends & Yields
BCYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.71% |
| Shareholder Yield | -0.71% |
| Earnings Yield | -56.19% |
| FCF Yield | -69.77% |
Analyst Forecast
The average price target for BCYC is $9.17, which is 153.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.17 |
| Price Target Difference | 153.23% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | -40.08% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BCYC has an Altman Z-Score of 1.44 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 3 |